Cargando…

PB2300: IMPACT OF INITIAL CHEMOTHERAPY CYCLES AND CLINICAL CHARACTERISTICS ON OUTCOMES FOR HIV-ASSOCIATED DIFFUSE LARGE B CELL LYMPHOMA PATIENTS: THE CENTRAL AND WESTERN CHINA AIDS LYMPHOMA LEAGUE STUDY

Detalles Bibliográficos
Autores principales: Wang, Chaoyu, Wu, Yan, Min, Haiyan, Huang, Yunhong, Liu, Yao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428867/
http://dx.doi.org/10.1097/01.HS9.0000975928.80298.86
_version_ 1785090573033537536
author Wang, Chaoyu
Wu, Yan
Min, Haiyan
Huang, Yunhong
Liu, Yao
author_facet Wang, Chaoyu
Wu, Yan
Min, Haiyan
Huang, Yunhong
Liu, Yao
author_sort Wang, Chaoyu
collection PubMed
description
format Online
Article
Text
id pubmed-10428867
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-104288672023-08-17 PB2300: IMPACT OF INITIAL CHEMOTHERAPY CYCLES AND CLINICAL CHARACTERISTICS ON OUTCOMES FOR HIV-ASSOCIATED DIFFUSE LARGE B CELL LYMPHOMA PATIENTS: THE CENTRAL AND WESTERN CHINA AIDS LYMPHOMA LEAGUE STUDY Wang, Chaoyu Wu, Yan Min, Haiyan Huang, Yunhong Liu, Yao Hemasphere Publication Only Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10428867/ http://dx.doi.org/10.1097/01.HS9.0000975928.80298.86 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Publication Only
Wang, Chaoyu
Wu, Yan
Min, Haiyan
Huang, Yunhong
Liu, Yao
PB2300: IMPACT OF INITIAL CHEMOTHERAPY CYCLES AND CLINICAL CHARACTERISTICS ON OUTCOMES FOR HIV-ASSOCIATED DIFFUSE LARGE B CELL LYMPHOMA PATIENTS: THE CENTRAL AND WESTERN CHINA AIDS LYMPHOMA LEAGUE STUDY
title PB2300: IMPACT OF INITIAL CHEMOTHERAPY CYCLES AND CLINICAL CHARACTERISTICS ON OUTCOMES FOR HIV-ASSOCIATED DIFFUSE LARGE B CELL LYMPHOMA PATIENTS: THE CENTRAL AND WESTERN CHINA AIDS LYMPHOMA LEAGUE STUDY
title_full PB2300: IMPACT OF INITIAL CHEMOTHERAPY CYCLES AND CLINICAL CHARACTERISTICS ON OUTCOMES FOR HIV-ASSOCIATED DIFFUSE LARGE B CELL LYMPHOMA PATIENTS: THE CENTRAL AND WESTERN CHINA AIDS LYMPHOMA LEAGUE STUDY
title_fullStr PB2300: IMPACT OF INITIAL CHEMOTHERAPY CYCLES AND CLINICAL CHARACTERISTICS ON OUTCOMES FOR HIV-ASSOCIATED DIFFUSE LARGE B CELL LYMPHOMA PATIENTS: THE CENTRAL AND WESTERN CHINA AIDS LYMPHOMA LEAGUE STUDY
title_full_unstemmed PB2300: IMPACT OF INITIAL CHEMOTHERAPY CYCLES AND CLINICAL CHARACTERISTICS ON OUTCOMES FOR HIV-ASSOCIATED DIFFUSE LARGE B CELL LYMPHOMA PATIENTS: THE CENTRAL AND WESTERN CHINA AIDS LYMPHOMA LEAGUE STUDY
title_short PB2300: IMPACT OF INITIAL CHEMOTHERAPY CYCLES AND CLINICAL CHARACTERISTICS ON OUTCOMES FOR HIV-ASSOCIATED DIFFUSE LARGE B CELL LYMPHOMA PATIENTS: THE CENTRAL AND WESTERN CHINA AIDS LYMPHOMA LEAGUE STUDY
title_sort pb2300: impact of initial chemotherapy cycles and clinical characteristics on outcomes for hiv-associated diffuse large b cell lymphoma patients: the central and western china aids lymphoma league study
topic Publication Only
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428867/
http://dx.doi.org/10.1097/01.HS9.0000975928.80298.86
work_keys_str_mv AT wangchaoyu pb2300impactofinitialchemotherapycyclesandclinicalcharacteristicsonoutcomesforhivassociateddiffuselargebcelllymphomapatientsthecentralandwesternchinaaidslymphomaleaguestudy
AT wuyan pb2300impactofinitialchemotherapycyclesandclinicalcharacteristicsonoutcomesforhivassociateddiffuselargebcelllymphomapatientsthecentralandwesternchinaaidslymphomaleaguestudy
AT minhaiyan pb2300impactofinitialchemotherapycyclesandclinicalcharacteristicsonoutcomesforhivassociateddiffuselargebcelllymphomapatientsthecentralandwesternchinaaidslymphomaleaguestudy
AT huangyunhong pb2300impactofinitialchemotherapycyclesandclinicalcharacteristicsonoutcomesforhivassociateddiffuselargebcelllymphomapatientsthecentralandwesternchinaaidslymphomaleaguestudy
AT liuyao pb2300impactofinitialchemotherapycyclesandclinicalcharacteristicsonoutcomesforhivassociateddiffuselargebcelllymphomapatientsthecentralandwesternchinaaidslymphomaleaguestudy